Sanovel İlaç
M.Murat Aktürk has extensive work experience in the pharmaceutical industry, with their most recent position being a Board Advisor at Sanovel İlaç since June 2022. Prior to that, they served as the Chief Executive Officer and General Manager at Sanovel İlaç from February 2020 to the present. M.Murat also held various sales and marketing roles within the company, including Sales and Marketing Group Director from October 2015 to September 2017, and Sales and Marketing Manager from December 2013 to October 2015. Before joining Sanovel İlaç, they worked at Bilim İlaç, where they held positions such as Business Unit Manager from October 2007 to July 2012, Senior Product Manager from January 2005 to October 2007, and Product Manager from January 2002 to January 2005. M.Murat started their career as a Marketing Trainee at Bilim İlaç from October 2001 to January 2002.
M.Murat Aktürk attended Kadıköy Anadolu Lisesi ve Maarif Koleji from 1985 to 1992 for their graduate studies. M.Murat then pursued further education at İstanbul University-Cerrahpaşa from 1993 to 1998, where they focused on İstanbul University.
This person is not in any offices
Sanovel İlaç
Sanovel, which produces at world standards without making any concessions to its principles and quality, was founded by Pharmacist Erol Toksöz. Having set up Ankara Galenos Pharmaceutical Warehouse in 1971, which is a step into the pharmaceutical industry, he purchased Adilna in 1982. He established Sanovel in 1983. Having started its production in Şişli, Sanovel today brings Turkish pharmaceutical industry to the future at modern facilities with an indoor space of 53,000 m2, located on an area of 125,000 m2. Having made a quick and stable improvement since its foundation, Sanovel is one of the leading companies in the pharmaceutical industry. Sanovel Pharmaceutical’s production facility, first laid foundation at İstanbul Silivri Çantaköy in 2001, fully started production as of November 2006. The production site comprises the main production unit, cephalosporin production unit, refining unit, elevated storage and social recreational facility. The production capacity is 227 million units per year. Closely following the developments in the world, Sanovel sets an example for the whole Turkish pharmaceutical industry, with the huge investments it makes in human resources and Research & Development studies.